Last reviewed · How we verify
Systemic cyclosporine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Systemic cyclosporine (Systemic cyclosporine) — Erasmus Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Systemic cyclosporine TARGET | Systemic cyclosporine | Erasmus Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Systemic cyclosporine CI watch — RSS
- Systemic cyclosporine CI watch — Atom
- Systemic cyclosporine CI watch — JSON
- Systemic cyclosporine alone — RSS
Cite this brief
Drug Landscape (2026). Systemic cyclosporine — Competitive Intelligence Brief. https://druglandscape.com/ci/systemic-cyclosporine. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing